We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Self-Propelled Microbots Navigate Blood Vessels

By LabMedica International staff writers
Posted on 13 Nov 2008
Print article
With the advent of nanotechnology, researchers are getting closer to creating a microscopic device that could swim through the bloodstream and directly pinpoint the site of disease, such as a tumor, which could potentially provide new treatment options. To reach to a tumor, however, such a device would have to be small and agile enough to navigate through a maze of tiny blood vessels, some much thinner than a human hair.

Researchers from the École Polytechnique de Montréal (QC, Canada), led by professor of computer engineering Dr. Sylvain Martel, have joined live, swimming bacteria to microscopic beads to develop a self-propelling device, called a nanobot. While other scientists have previously attached bacteria to microscopic particles to exploit their natural propelling motion, Dr. Martel's team is the first to demonstrate that such hybrids can be navigated through the body utilizing magnetic resonance imaging (MRI) technology.

To do this, the investigators used bacteria that naturally contain magnetic particles. In a natural environment, these particles help the bacteria navigate toward deeper water, away from oxygen. However, by altering the neighboring magnetic field using an extended set-up attached to an MRI machine, the researchers were able to induce the bacteria to move themselves in any direction they wanted.

The bacteria move using tiny corkscrew-like tails called flagella, and these specific bacteria are faster and stronger than most, according to Dr. Martel. Moreover, they are only two microns in diameter--small enough to fit through the smallest blood vessels in the human body. The team treated the polymer beads approximately 150 nanometers in size with antibodies so that the bacteria would attach to them. Eventually, the researchers plan to modify the beads so that they also carry cancer-killing drugs.

In 2007, Dr. Martel and his group published a study in the journal Applied Physics Letters describing how they utilized an MRI machine to maneuver a 1.5-mm magnetic bead with a bacteria propeller through the carotid artery of a living pig at 10-cm per second. The investigators latest study, presented at the IEEE 2008 Biorobotics Conference, held in Scottsdale, AZ, USA, October 2008, revealed that they could track and steer microbeads and bacteria or bacteria alone through a facsimile of human blood vessels using the same approach. The investigators have performed similar experiments in rats and rabbits, according to Dr. Martel.

The bacterial microbots, however, would not be able to work in larger blood vessels in on their own. The current would be too strong for them to swim against it. Therefore, the researchers envisage using a larger, magnetically maneuverable micro-vehicle to carry the microbots close to a tumor. According to Dr. Martel, the vehicle would have to be composed of a polymer or something similar to release the bacteria while the vehicle remains there and dissolves

Dr. Martel's vehicle contains magnetic nanoparticles and it can be moved at approximately 200 microns per second. He reported that he and his team corrected the micro-vehicle's path approximately 30 times a second. While they have developed the micro-vehicle and bacterial microbots independently, they are now working to combine the two technologies. They are positive that they will soon succeed in that endeavor.

Contrariwise, however, other investigators have suggested that it could be difficult to maintain normal blood flow and to retrieve the magnetic particles from the body after the procedure is complete. Some researchers also question whether the body's immune system would attack the bacteria before they could reach a tumor, but Dr. Martel stated that he is very confident that this will not be a problem. Because the immune system has not encountered these bacteria before, he noted, it would not have time to destroy the microbots before they reach their target.

Related Links:
École Polytechnique de Montréal

New
Gold Member
Thyroid Stimulating Hormone Assay
TSH EIA 96 Test
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Urine Collection Container
Urine Monovette
New
Leishmania Test
Leishmania Real Time PCR Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Small molecule modulation of protein corona significantly enhances deep plasma proteome profiling (Photo courtesy of Mahmoudi Group)

Smarter Blood Tests Deliver Faster Diagnoses and Improved Outcomes

It has long been established that the earlier a disease is detected, the better the chances for a positive patient outcome. A novel method now offers an in-depth analysis of proteins in plasma, uncovering... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: Photoacoustic images of a splayed vessel structure underlying very light and dark skin tones (Photo courtesy of asquinha, Gubbi, and Bell, doi 10.1117/1.BIOS.2.1.012502)

New Imaging Technique Reduces Skin Tone Bias in Breast Cancer Detection

Breast cancer remains a significant global health issue, and early detection is key to successful treatment. Traditional imaging techniques like mammography often face challenges, particularly for women... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.